TJM Labs
TJM Labs is an AI-powered pharmacy automation company that uses Vision AI and a pharmacist-plus-engineer delivery model to automate prescription intake, data entry, refills, and patient calls across 400+ compounding, specialty, long-term care, and retail pharmacies in the US and Canada.
- Company typePrivate
- Founded2025
- HeadquartersWilmington, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What TJM Labs does
TJM Labs is a private, Delaware-incorporated AI software company that automates repetitive workflows inside pharmacies without replacing existing systems. Its platform pairs licensed pharmacists with automation engineers under a Dual-Expert Model and uses computer vision and large language models to drive bots directly through pharmacy management system interfaces (BestRx, PioneerRx, PrimeRx, QS/1, Liberty, Scriptly, RedSail, TELUS Health, Pharmetika, SiCompounding), avoiding API or rip-and-replace integration. The product portfolio spans TJM Bot (prescription intake, data entry, refills, prior authorizations), TJM Retail Bot (plug-and-play for independent pharmacies), VoiceAI (24/7 patient phone automation), Provider Portal (structured prescription submission for compounders), and the acquired Pharmesol voice platform.
The company serves four primary verticals (compounding, specialty, long-term care, and retail/independent pharmacies) across the US and Canada, claiming support for 400+ pharmacies and 300,000+ prescriptions processed daily through its PCCA channel partnership alone. Named enterprise customers include Gifthealth (25,000+ prescriptions/day, 150 active bots, $25M annual savings reported), LinkRx (6,640 prescriptions/day, 10x ROI), Zeal Specialty Pharmacy, Walberg Family Pharmacies, and Triangle, Valor, and VEPO compounding operations.
TJM Labs monetizes through a mix of custom multi-year enterprise contracts (with forward-deployed engineers, dedicated teams, custom SLAs, and multi-product bundling) and a publicly priced Provider Portal subscription (Starter $299/month up to a custom tier above 6,000 scripts/month). Enterprise economics are anchor-driven, with 50% of revenue from 10 enterprise customers covering 200+ locations and 3M+ scripts per month. The company raised a $10M Series A led by Arthur Ventures in November 2025 (first sale December 19, 2025) at a $20M post-money valuation, has 70 employees across four regions, and is HIPAA-compliant with SOC 2 Type 2 and HITRUST CSF posture.
TJM Labs firmographics
Firmographics- Name
- TJM Labs
- Legal name
- TJM Labs, LLC
- Website
- https://tjmlabs.com/
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- TJM Labs is an AI-powered pharmacy automation company that uses Vision AI and a pharmacist-plus-engineer delivery model to automate prescription intake, data entry, refills, and patient calls across 400+ compounding, specialty, long-term care, and retail pharmacies in the US and Canada.
- Ownership category
- akta.pro rank
TJM Labs industry classification
Industry- Product category
- Pharmacy Automation Software
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- akta.pro primary industry
- Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)
Keywords
Where TJM Labs is headquartered
LocationHeadquarters
- HQ city
- Wilmington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
TJM Labs business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Subscription - Provider Portal: Monthly subscription pricing based on prescription volume with three tiers (Starter, Growth, Scale) plus custom enterprise pricing. No setup fees. Includes catalog setup and provider onboarding.
- Enterprise Automation Contracts: Custom enterprise contracts with forward-deployed engineers, dedicated teams, and custom SLAs. 50% of revenue from 10 enterprise customers with 200+ locations served. Multiple products (TJM Bot, VoiceAI, Provider Portal) deployed together.
- Series A Investment: Raised $10 million in Series A funding led by Arthur Ventures in November 2025, with first sale on December 19, 2025.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Starter: $299/month for 1,000 scripts/month |
| Subscription | Monthly | Growth: $799/month for 3,000 scripts/month |
| Subscription | Monthly | Scale: $1,499/month for 6,000 scripts/month |
| Subscription | Multi-year contract | Custom: Contact sales for 6,000+ scripts/month |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
TJM Labs product offering
Product offeringCore offering
TJM Labs sells an AI-powered pharmacy automation platform that uses Vision AI to interact directly with existing pharmacy management system (PMS) interfaces, automating prescription intake, data entry, refill processing, prior authorizations, and patient phone communications. The platform comprises TJM Bot, TJM Retail Bot, Provider Portal, and VoiceAI, sold as subscription SaaS to compounding, specialty, long-term care, and retail/independent pharmacies.
Product overview
TJM Labs offers a unified AI-powered pharmacy automation platform designed to automate repetitive pharmacy tasks without replacing existing systems. The core portfolio consists of TJM Bot (primary automation for prescription intake and data entry), TJM Retail Bot (for retail pharmacy), VoiceAI (24/7 phone automation for patient communications), and Provider Portal (structured prescription submission). These products work independently or together as integrated modules, powered by the Dual-Expert Model that pairs pharmacists with engineers. TJM Labs serves compounding, specialty, long-term care, retail, and independent pharmacies across the US and Canada, processing over 3 million prescriptions monthly.
Differentiator
Problem solved
Functional benefit
Brands
- TJM Bot: AI-powered automation bot for prescription intake, data entry, and pharmacy workflow automation.
- TJM Retail Bot
- Provider Portal
- VoiceAI
- TJM Portal
- Pharmesol
Products and services
- TJM Bot AI-powered automation bot that handles prescription intake, data entry, refill processing, prior authorizations, and patient communications by working through existing pharmacy management system interfaces via Vision AI, eliminating the need for APIs or system replacements. Targeted at compounding, specialty, and large-scale pharmacy operations.
- TJM Retail Bot Plug-and-play automation bot designed for retail and independent pharmacy workflows requiring no customization and going live in days; automates prescription intake, refill management, and patient communication for independent and retail pharmacies.
- Provider Portal White-labeled, structured prescription submission portal for compounding pharmacies that lets providers submit clean scripts in 30 seconds via a three-tap process, eliminating fax deciphering and manual re-keying; delivered as subscription tiers based on monthly prescription volume.
- VoiceAI AI-powered voice automation that handles inbound and outbound pharmacy calls 24/7 with natural conversation (no phone trees), processing refill requests, order status, appointment confirmations, and patient communications; HIPAA-compliant and URAC-compliant for specialty pharmacy.
Quantifiable outcome
- 10x ROI on automation investment for specialty compounding pharmacies
- +9 more outcomes
Companies that use TJM Labs
Customer profileNamed customers10 records
Segments6 records
Ideal customer profiles4 records
TJM Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability9 records
Feature6 records
TJM Labs partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- PCCA (Professional Compounding Centers of America)corePCCA, a 45-year-old Houston-based provider of compounding pharmacy products and support, named TJM Labs its official automation partner. TJM Labs provides AI-powered workflow automation including AI bots for prescription intake, data entry, prior authorizations, and patient communication to PCCA's member pharmacies. Partnership gives PCCA members access to technology supporting over 400 pharmacies processing more than 300,000 prescriptions daily.
- Alliance for Pharmacy Compounding (APC)minorCorporate Patron partnership with APC, the leading voice representing the pharmacy compounding profession. TJM Labs engages with APC members and stakeholders to support best practices and continuous improvement. Team members actively involved across APC committees, working groups, and knowledge-sharing opportunities.
Scale indicators7 records
Recent moves6 records
Expansion highlights3 records
TJM Labs competitors and assessment
Company assessmentBroad incumbents
- Surescripts: Nationwide prescription data network and clinical messaging backbone for pharmacies, providers, and PBMs. Sits at the rail layer TJM Labs' bots traverse, making it both a potential partner and a competitor as it expands into workflow automation.
- ScriptPro: Pharmacy workflow, dispensing, and robotic automation vendor serving retail and hospital pharmacies. Comparable pharmacy automation category but historically focused on dispensing robotics rather than AI workflow agents.
- Omnicell: Large pharmacy automation and medication management company spanning hardware, software, and adherence packaging. Broader incumbent portfolio than TJM Labs' software-only stack but competes for pharmacy automation budgets.
- Innovation Associates (Omnicell): Pharmacy central fill and high-volume dispensing automation now part of Omnicell. Comparable in automating high-volume pharmacy workflows, though anchored to large-scale central fill operations.
Direct peers
- DoseSpot: ePrescribing and medication management software purpose-built for pharmacies, dental, and ambulatory practices. Closely comparable in automating prescription workflows for pharmacy operators, with overlapping target buyer personas.
- DrFirst: ePrescribing, clinical messaging, and medication management platform used by pharmacies and providers. Comparable in automating prescription intake and clinical data workflows, though historically API/integration-led rather than Vision AI.
- CoverMyMeds (McKesson): McKesson-owned prior authorization and medication management platform serving pharmacies, providers, and payers. Direct overlap with TJM Labs' prior authorization and patient communication automation, but with a broader, incumbent footprint.
Emerging players
- RxSafe: Pharmacy automation hardware and workflow software provider focused on adherence packaging and dispensing. Smaller scale than Omnicell/ScriptPro but competes for the same pharmacy technology wallet.
- PipelineRx (Cureatr): Pharmacy clinical services and medication management platform serving health systems and pharmacies. Adjacent overlap in clinical pharmacy workflow automation, particularly for specialty and hospital-adjacent pharmacies.
Regional players
- Asteres (Veradigm): Prescription pickup and dispensing kiosk automation vendor, now part of Veradigm (Allscripts). Less directly overlapping on AI workflow automation but competes for pharmacy technology budgets at the point of dispensing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
TJM Labs social profiles
Digital presenceTJM Labs compliance and trust
Trust signalCompliance3 records
TJM Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
TJM Labs leadership team
Management profileNumber of profiles
Profiles2 records
TJM Labs subsidiaries and ownership
Company hierarchySubsidiaries1 record
TJM Labs funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TJM Labs M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TJM Labs
What does TJM Labs do?
TJM Labs sells an AI-powered pharmacy automation platform that uses Vision AI to interact directly with existing pharmacy management system (PMS) interfaces, automating prescription intake, data entry, refill processing, prior authorizations, and patient phone communications. The platform comprises TJM Bot, TJM Retail Bot, Provider Portal, and VoiceAI, sold as subscription SaaS to compounding, specialty, long-term care, and retail/independent pharmacies.
Is TJM Labs a public or private company?
TJM Labs is a private company. It is classified as venture growth investor backed and is currently operating.
When was TJM Labs founded?
TJM Labs was founded in 2025. It employs 51 to 100 people.
Where is TJM Labs based?
TJM Labs is headquartered in Wilmington, United States, in the North America region.
How does TJM Labs make money?
Three revenue lines are on record. SaaS Subscription - Provider Portal is the primary driver. The others are enterprise Automation Contracts and series A Investment.
Who are TJM Labs's main competitors?
Broad incumbents on record are Surescripts, ScriptPro, Omnicell and Innovation Associates (Omnicell). Direct peers are DoseSpot, DrFirst and CoverMyMeds (McKesson). Emerging players are RxSafe and PipelineRx (Cureatr). Asteres (Veradigm) is listed as a regional player.
Does TJM Labs have an API?
No public API is recorded for TJM Labs.
What industry is TJM Labs in?
TJM Labs's product category is Pharmacy Automation Software. Its primary akta.pro industry code is HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy). Its NAICS code is 524292.